InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.886
-0.034 (-3.73%)
At close: Mar 9, 2026, 4:00 PM EDT
0.790
-0.096 (-10.81%)
After-hours: Mar 9, 2026, 7:56 PM EDT

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
44231026
Upgrade
Market Cap Growth
-12.09%65.68%-23.21%-68.01%-62.35%-20.62%
Upgrade
Enterprise Value
-30-4-6516
Upgrade
Last Close Price
0.923.255.3118.53235.201590.00
Upgrade
PS Ratio
0.770.790.520.758.85-
Upgrade
PB Ratio
0.270.290.260.261.063.47
Upgrade
P/TBV Ratio
0.430.330.320.301.384.05
Upgrade
EV/Sales Ratio
-0.01--4.24-
Upgrade
Debt / Equity Ratio
0.060.060.110.030.090.04
Upgrade
Net Debt / Equity Ratio
-0.67-0.77-0.61-0.71-0.60-0.97
Upgrade
Net Debt / EBITDA Ratio
0.851.350.711.050.410.73
Upgrade
Net Debt / FCF Ratio
0.871.340.811.150.350.73
Upgrade
Asset Turnover
0.460.360.360.310.10-
Upgrade
Inventory Turnover
3.092.942.441.33--
Upgrade
Quick Ratio
4.856.303.534.611.903.35
Upgrade
Current Ratio
5.946.994.415.662.893.78
Upgrade
Return on Equity (ROE)
-97.20%-72.10%-72.08%-75.09%-226.07%-153.95%
Upgrade
Return on Assets (ROA)
-49.77%-36.12%-39.22%-38.94%-75.28%-70.65%
Upgrade
Return on Capital Employed (ROCE)
-80.70%-57.60%-82.60%-69.20%-143.60%-131.40%
Upgrade
Earnings Yield
-221.57%-208.04%-324.14%-257.74%-192.96%-39.86%
Upgrade
FCF Yield
-214.56%-197.97%-295.41%-241.44%-162.08%-38.25%
Upgrade
Buyback Yield / Dilution
-359.88%-156.13%-211.26%-336.59%-108.64%-28.72%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.